Ototoxicity from ototopical aminoglycosides

Journal of Otolaryngology

Volumn 26, Issue 1, 1997, Pages 53-56

  Hui, Yau ^a   Park, Albert ^a   Crysdale, William S ^a   Forte, Vito ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CORTISPORIN; FRAMYCETIN; GENTAMICIN; GRAMICIDIN; SOFRACORT; TOBRAMYCIN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CASE REPORT; HUMAN; MALE; MIDDLE EAR VENTILATION; OTITIS MEDIA; OTOTOXICITY; PERCEPTION DEAFNESS; PRESCHOOL CHILD; PRIORITY JOURNAL;

ADMINISTRATION, TOPICAL; ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; AUDIOMETRY, PURE-TONE; DEXAMETHASONE; DRUG THERAPY, COMBINATION; FRAMYCETIN; GENTAMICINS; GRAMICIDIN; HEARING LOSS, CONDUCTIVE; HUMANS; MALE; OTITIS MEDIA WITH EFFUSION; TYMPANIC MEMBRANE PERFORATION;

EID: 0030890182     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Free WE Jr. Aminoglycoside ototoxicity in the human. Laryngoscope 1980; 90(suppl):1-19.
2. Goycoolea MV, Paparella MM, Burt Goldberg MS, et al. Permeability of the round window in otitis media. Arch Otolaryngol 1980; 106: 430-433.
3. Harada T, Nagai Y, Iwamori M, Nomura Y. Ototoxicity of neomycin and its penetration through the round window membrane into the perilymph. Ann Otol Rhinol Laryngol 1986; 95:404-408.
4. Smith SM, Myers, MG. The penetration of gentamicin and neomycin into perilymph across the round window membrane. Otolaryngol Head Neck Surg 1979; 87:888-891.
5. Wright CG, Halama AR, Meyerhoff WL. Ototoxicity of a ototopical preparation in a primate. Am J Otol 1987; 8:56-60.
6. Lind O, Kristiansen B. Deafness after treatment with ear drops containing neomycin, geramicidin and germathasone: a case report. ORL 1986; 48:52-54.
7. Leliever WC. Topical gentamicin-induced positional vertigo. Otolaryngol Head Neck Surg 1985; 93:553-555.
8. Murphy KW. Deafness after topical neomycin. BMJ 1970; 2:114.
9. Tommerkup B, Moller K. A case of profound hearing impairment following the primary use of framycetin ear drops. J Laryngol Otol 1984; 98:1135-1137.
10. Roland PS. Clinical ototoxicity of topical antibiotic drops. Otolaryngol Head Neck Surg 1994; 110:598-602.
11. Lundy LB, Graham MD. Ototoxicity and ototopical medications: a survey of otolaryngologists. Am J Otol 1993; 14: 141-146.
12. 11a. Nomura Y. Otological significance of the round window. In: Pfoltz CR, ed. Advances in Oto-Rhino-Laryngology. Vol 33. New York: S. Karger, 1984:1-164.
13. Podoshin L, Fradis M, Bendavid J. Ototoxicity of ear drops in patients suffering from chronic otitis media. J Laryngol Otol 1989; 103: 46-50.
14. Morizono T. Ototopical agents: ototoxicity in animal studies. In: Bluestone CD, Kenna MA, Scheetz MD, eds. Workshop on chronic suppurative otitis media: etiology and management. Ann Otol Rhinol Laryngol 1988; 97(Suppl 131): 28-30.
15. Morizono T. Toxicity of ototopical drops: animal modeling. Ann Otol Rhinol Laryngol 1990; 99:42-45.
16. Brown OE, Meyerhoff WL. topical agents: efficacy or treatment in humans. In: Bluestone CD, Kenna MA, eds. Workshop on chronic suppurative otitis media: etiology and management. Ann Otol Rhinol Laryngol 1988; 97(Suppl 131): 38-40.
17. Nedzelski JMN. Chemical labyrinthectomy: local application of gentamicin for the treatment of unilateral Meniere's disease. Trans Am Otol Soc 1991; 79:144-148.
18. Longridge NS. Topical gentamicin vestibular toxicity. J Otolaryngol 1994; 23:444-446.
19. Dumas G, et al. Malformations on the bony labyrinth and deafness. Ann Otolaryngol Chir Cervicofac 1991; 108:1-12.